Stockreport

XBiotech Announces Enrollment Completion, Positive Findings for Bermekimab in Pancreatic Cancer Study

XBiotech Inc.  (XBIT) 
Last xbiotech inc. earnings: 8/9 03:01 pm Check Earnings Report
US:NASDAQ Investor Relations: xbiotech.com/about/investors.html
PDF AUSTIN, Texas, May 02, 2019 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) announced today enrollment of the final patient into its Phase I study1 evaluating bermeki [Read more]